Clinical Roundup MD Anderson, Sibylla Biotech collaborate to develop small-molecule protein degraders June 14, 2024Vol.50 No.24
Clinical Roundup Atlantic Health System, Mevion collaborate to bring proton therapy technology to Carol G. Simon Cancer Center June 14, 2024Vol.50 No.24
Clinical Roundup Black patients who receive docetaxel for breast cancer experience less peripheral neuropathy than those who receive paclitaxel June 07, 2024Vol.50 No.23
Clinical Roundup Sarclisa combination improves PFS in newly diagnosed transplant-ineligible MM in phase III trial June 07, 2024Vol.50 No.23
Clinical Roundup Enhertu demonstrated median PFS of 13.2 months in IHC 1+ or IHC 2+/ISH- metastatic breast cancer in phase III trial June 07, 2024Vol.50 No.23
Clinical Roundup Opdivo + Yervoy improves OS for advanced hepatocellular carcinoma in phase III trial June 07, 2024Vol.50 No.23
Clinical Roundup Updated analyses from 3 phase III trials continue to support Opdivo and its combinations for NSCLC June 07, 2024Vol.50 No.23
Clinical Roundup Proton therapy demonstrates advantages for head and neck cancer in phase III trial preliminary data June 07, 2024Vol.50 No.23
Clinical Roundup Obe-cel yields strong remission rates in adults with relapsed or refractory B-ALL in phase Ib/II study June 07, 2024Vol.50 No.23
Clinical Roundup Shorter durations of venetoclax yields similar response rates in AML June 07, 2024Vol.50 No.23
